Scientists discover 'death complex' that could worsen Alzheimer's

Key Points:

• Researchers from Heidelberg University and Shandong University identified a molecular "death switch" involving the interaction between NMDA receptors and TRPM4 ion channels that contributes to nerve cell death and cognitive decline in Alzheimer's disease.
• The experimental drug FP802 was found to block this harmful interaction, breaking apart the neurotoxic complex, which slowed disease progression in a mouse model of Alzheimer's.
• FP802 also prevented typical cellular damage such as synapse loss and mitochondrial dysfunction, preserved learning and memory abilities, and significantly reduced amyloid beta deposits in the brain.
• Unlike traditional treatments that target amyloid formation or removal, this approach blocks a downstream cellular mechanism responsible for nerve cell death and amyloid accumulation.
• While promising, FP802 requires further pharmacological development, toxicology testing, and clinical trials before it can be considered for human use, and researchers hope it may also benefit other neurodegenerative diseases like ALS.